Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$60.5M
-19.9% from 2023
Prescriptions
473K
$127.81 per claim
Patients
106K
76,693 prescribers
Total spending, 2024
$60.5M
$572.00 per patient
Medicare prescription drug plans paid $60.5M for Clonidine in 2024, for 473,474 prescriptions and refills to 105,797 patients (down 19.9% from 2023). The average cost per claim was $127.81.
California had the highest Medicare cost for Clonidine in 2024: $7.2M for 60,463 claims, followed by Texas ($5.4M).
Vagharshak M Pilossyan, internal medicine in Van Nuys, CA, had the highest Medicare cost for Clonidine in 2024: 895 claims costing $48K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Vagharshak M Pilossyan Van Nuys, CA | Internal Medicine | 895 | 96 | $48K |
| William H Heaton Florence, AL | Cardiology | 394 | 90 | $46K |
| Paramjit S Takhar |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 73,841 | 451,149 | 101,191 | $76.1M |
| 2023 | 74,613 | 458,752 | 102,430 | $75.6M |
| 2024 | 76,693 | 473,474 | 105,797 | $60.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 243 |
| 84 |
| $38K |
| Ricardo G Cigarroa Laredo, TX | Internal Medicine | 256 | 81 | $34K |
| James M Parks Birmingham, AL | Cardiology | 239 | 45 | $32K |
| Shashi K Sharma Visalia, CA | Cardiology | 166 | 49 | $31K |
| Dimple Agarwal Palm Springs, CA | Internal Medicine | 193 | 60 | $30K |
| Grigoriy Goldenberg Brooklyn, NY | Internal Medicine | 448 | 60 | $29K |
| Stuart L Horwitz Washington, DC | Gastroenterology | 188 | 28 | $29K |
| Hajir E Dilmanian Brooklyn, NY | Nuclear Medicine | 103 | 33 | $27K |
| Steven G Clark Cleveland, MS | Internal Medicine | 255 | 55 | $25K |
| John S Fischer Ashland, AL | Family Practice | 251 | 42 | $25K |
| Evgueni Roudachevski Little Rock, AR | Geriatric Medicine | 227 | 42 | $24K |
| Nouneh O Danielyan Los Angeles, CA | Internal Medicine | 319 | 35 | $24K |
| Gerardo E Arnaez Zapata Durham, NC | Internal Medicine | 192 | 28 | $24K |
| Kevin C Scott Wyncote, PA | Family Practice | 143 | 28 | $23K |
| Arsen Hovanesyan Montrose, CA | Cardiology | 221 | 27 | $23K |
| Hed Ahmadpour Lakewood, CA | Cardiology | 215 | 41 | $23K |
| Vivienne E Smith Albany, NY | Cardiology | 295 | 55 | $23K |
| Fernando Segovia Edgewater, NJ | Interventional Cardiology | 156 | 49 | $23K |
| Traian M Anghel East Syracuse, NY | Clinical Cardiac Electrophysiology | 280 | 47 | $22K |
| Vivek Khetpal Durant, OK | Cardiology | 144 | 44 | $22K |
| Tsovinar Tekkelian Glendale, CA | Internal Medicine | 273 | 36 | $22K |
| Aniano N Cabrera Garcia Miami, FL | Family Practice | 127 | 19 | $22K |
| Joaquin Solis Milwaukee, WI | Interventional Cardiology | 126 | 29 | $22K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Actavis/Teva TEVA | 166,326 | $22.8M |
| Mylan VTRS | 105,091 | $14.5M |
| Dr.Reddy'S Lab RDY | 116,067 | $13.5M |
| Mayne Pharma In | 72,960 | $8.2M |
| Trupharma, LLC. | 13,190 | $1.5M |